BRAF V600E Mutation Status in Anaplastic Thyroid Carcinoma

被引：0
|
作者：
Nonaka, Daisilke
Rushton, Sarah
Burghel, George
Wallace, Andrew
机构：
[1] Christie Hosp, Manchester, Lancs, England
[2] Univ Manchester, Manchester, Lancs, England
[3] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester, Lancs, England
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
544
引用
收藏
页码：139A / 139A
页数：1
相关论文
共 50 条
  • [21] Investigation of Mismatch Repair Protein, BRAF V600E Mutation, and P53 Expression in Thyroid Anaplastic Carcinoma
    Lai, Wei-An
    Hang, Jen-Fan
    MODERN PATHOLOGY, 2019, 32
  • [22] Investigation of Mismatch Repair Protein, BRAF V600E Mutation, and P53 Expression in Thyroid Anaplastic Carcinoma
    Lai, Wei-An
    Hang, Jen-Fan
    LABORATORY INVESTIGATION, 2019, 99
  • [23] Association between the BRAF V600E mutation and ultrasound features of the thyroid in thyroid papillary carcinoma
    Li, Qian
    Yuan, Jianjun
    Wang, Yan
    Zhai, Yuanpeng
    ONCOLOGY LETTERS, 2017, 14 (02) : 1439 - 1444
  • [24] BRAF (V600E) mutation in isthmic malignant thyroid nodules
    Campenni, A.
    Giovanella, L.
    Alibrandi, A.
    Siracusa, M.
    Ruggeri, R. M.
    Baldari, S.
    CLINICAL ENDOCRINOLOGY, 2016, 84 (01) : 152 - 153
  • [25] Immunohistochemical expression of BRAF V600E mutation in thyroid lesions
    Kyrodimou, E.
    Koutsonikas, G.
    Kostopoulou, A.
    Minaidou, E.
    Papanastasiou, L.
    Theodosiou, D.
    Choreftaki, T.
    VIRCHOWS ARCHIV, 2014, 465 : S213 - S213
  • [26] BRAF V600E Mutation and Papillary Thyroid Cancer Reply
    Cappola, Anne R.
    Mandel, Susan J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (05): : 535 - 536
  • [27] BRAF(V600E) mutation and the biology of papillary thyroid cancer
    Frasca, F.
    Nucera, C.
    Pellegriti, G.
    Gangemi, P.
    Attard, M.
    Stella, M.
    Loda, M.
    Vella, V.
    Giordano, C.
    Trimarchi, F.
    Mazzon, E.
    Belfiore, A.
    Vigneri, R.
    ENDOCRINE-RELATED CANCER, 2008, 15 (01) : 191 - 205
  • [28] Vemurafenib selectively radiosensitizes BRAF V600E mutant papillary and anaplastic thyroid carcinoma cells
    Robb, Ryan N.
    Yang, Linlin
    Williams, Terence
    CANCER RESEARCH, 2017, 77
  • [29] BRAF overexpression is associated with BRAF V600E mutation in papillary thyroid carcinomas
    da Silva, R. C.
    de Paula, H. S. C.
    Leal, C. B. Q. S.
    Cunha, B. C. R.
    de Paula, E. C.
    Alencar, R. C. G.
    Meneghini, A. J.
    Silva, A. M. T. C.
    Gontijo, A. P.
    Wastowski, I. J.
    Saddi, V. A.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02) : 5065 - 5075
  • [30] Braf V600E mutation analysis in low and intermediate risk papillary thyroid carcinoma
    Lopez Villar, I.
    Navarro Martinez, T.
    Jane Soler, P.
    Bonilla Plaza, J.
    Martinez Lorca, A.
    Perez Iruela, J.
    Orduna Diez, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S71 - S72
12345